This inventor holds 1 USPTO granted patent. Top assignee: Federalnoe Gosudarstvennoe Unitarnoe Predpriyatie “Gosudarstvenny Nauchny Tsentr Nauchno-Issledovatelsky Institut Organicheskikh Poluproduktov I Krasitelei” (Fgup “Gntts Niopik”). Active years: 2008.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2008
Title: Innovations in Photodynamic Therapy by Sergei Georgievich Kuzmin
Introduction
Sergei Georgievich Kuzmin is a notable inventor based in Dolgoprudny, Moscow Oblast, Russia. He has made significant contributions to the field of medicine, particularly in photodynamic therapy, which is crucial for treating various pathological conditions.
Latest Patents
Kuzmin holds a patent for a method for photodynamic therapy and an applicator designed for its implementation. This innovative method involves sensitizing the surface of pathological areas using an applicator containing 5-aminolevulinic acid. The therapy is enhanced by irradiating the sensitized area with therapeutic optical radiation in the spectral range of 625-700 nm. The applicator is transparent in this range, allowing for effective treatment while monitoring the intensity of fluorescence in the tissues.
Career Highlights
Kuzmin is associated with the Federal State Unitary Enterprise "State Scientific Center for Research of Organic Intermediate Products and Dyes" (Fgup "Gntts Niopik"). His work focuses on improving the efficacy of photodynamic therapy while minimizing the use of 5-aminolevulinic acid, showcasing his commitment to advancing medical technology.
Collaborations
Kuzmin has collaborated with esteemed colleagues such as Georgy Nikolaevich Vorozhtsov and Anatoly Borisovich Davydov. Their combined expertise contributes to the innovative developments in the field of photodynamic therapy.
Conclusion
Sergei Georgievich Kuzmin's contributions to photodynamic therapy represent a significant advancement in medical treatment options. His innovative methods and collaborative efforts continue to enhance the efficacy of therapies used in oncology and dermatology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile